UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance

Blood, 2016-01, Vol.127 (1), p.29-41

2016

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults

The international journal of behavioral nutrition and physical activity, 2010-05, Vol.7 (1), p.39-39

2010

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Minimal Residual Disease in Standard-Risk AML

The New England journal of medicine, 2016-02, Vol.374 (5), p.422-433

2016

Link zum Volltext

Verfügbarkeit prüfen

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome

Blood, 2022-12, Vol.140 (22), p.2407-2411

2022

Link zum Volltext

Verfügbarkeit prüfen

Exercise volume and intensity: a dose–response relationship with health benefits

European journal of applied physiology, 2014-08, Vol.114 (8), p.1563-1571

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia

Blood advances, 2021-12, Vol.5 (23), p.5107-5111

2021

Link zum Volltext

Verfügbarkeit prüfen

Acute myeloid leukaemia with mutated NPM1 presenting with extensive bone marrow necrosis and Charcot–Leyden crystals

International journal of hematology, 2013-09, Vol.98 (3), p.267-268

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term ultra-marathon running and arterial compliance

Journal of science and medicine in sport, 2014-05, Vol.17 (3), p.322-325

2014

Link zum Volltext

Verfügbarkeit prüfen

Physiological demands of downhill mountain biking

Journal of sports sciences, 2012-12, Vol.30 (16), p.1777-1785

2012

Link zum Volltext

Verfügbarkeit prüfen

Characterisation of baroreflex sensitivity of recreational ultra-endurance athletes

European journal of sport science, 2014-01, Vol.14 (7), p.686-694

2014

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy

Journal of clinical oncology, 2020-10, Vol.38 (30), p.3506-3517

2020

Link zum Volltext

Verfügbarkeit prüfen

Intensified Induction Chemotherapy Results in More Rapid Early NPM1 Mutant (mut) Measurable Residual Disease (MRD) Clearance but Similar Disease Outcomes

Blood, 2022-11, Vol.140 (Supplement 1), p.6258-6259

2022

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Phase 2 Study of Venetoclax and Low Dose Ara-C (VALDAC) to Target Rising Molecular Measurable Residual Disease and Early Relapse in Acute Myeloid Leukemia

Blood, 2022-11, Vol.140 (Supplement 1), p.1453-1455

2022

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia

British journal of haematology, 2021-03, Vol.192 (6), p.1026-1030

2021

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Phase 2 Study of Venetoclax and Low Dose Ara-C (VALDAC) to Target Rising Molecular Measurable Residual Disease and Early Relapse in Acute Myeloid Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.1261-1261

2021

Link zum Volltext

Verfügbarkeit prüfen

Cellular distribution of IDH mutations in AML during morphologic remission

Leukemia research, 2023-01, Vol.124, p.106993-106993, Article 106993

2023

Link zum Volltext

Verfügbarkeit prüfen

High Sensitivity Detection of FLT3-ITD Measurable Residual Disease By Deep Sequencing Prior to Hematopoietic Cell Transplant Is Highly Prognostic for Outcome in Acute Myeloid Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.2364-2364

2021

Link zum Volltext

Verfügbarkeit prüfen

Germline Missense Variants in SH2B3 Underpin Platelet Count Variation and Inherited MPN

Blood, 2022-11, Vol.140 (Supplement 1), p.1093-1094

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(80)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(86)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(30)
Male
(16)
Female
(15)
Hematology
(13)
Middle Aged
(13)
Adult
(12)
Leukemia, Myeloid, Acute - Genetics
(12)
Aged
(10)
Mutation
(9)
Nuclear Proteins - Genetics
(9)
Leukemia, Myeloid, Acute - Drug Therapy
(7)
Nucleophosmin
(7)
Leukemia, Myeloid, Acute - Pathology
(6)
Physiology
(6)
Prognosis
(6)
Immunology
(5)
Leukemia, Myeloid, Acute - Therapy
(5)
Sport Sciences
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance

A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults

Assessment of Minimal Residual Disease in Standard-Risk AML

Molecular MRD status and outcome after transplantation in NPM1-mutated AML

Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome

Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

Exercise volume and intensity: a dose–response relationship with health benefits

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia

P503: A RANDOMISED TRIAL OF MOLECULAR MONITORING VERSUS STANDARD CLINICAL CARE IN YOUNGER ADULTS WITH ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE UK NCRI AML17 AND AML19 STUDIES

Acute myeloid leukaemia with mutated NPM1 presenting with extensive bone marrow necrosis and Charcot–Leyden crystals

Long-term ultra-marathon running and arterial compliance

Physiological demands of downhill mountain biking

Characterisation of baroreflex sensitivity of recreational ultra-endurance athletes

Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy

Intensified Induction Chemotherapy Results in More Rapid Early NPM1 Mutant (mut) Measurable Residual Disease (MRD) Clearance but Similar Disease Outcomes

A Prospective Phase 2 Study of Venetoclax and Low Dose Ara-C (VALDAC) to Target Rising Molecular Measurable Residual Disease and Early Relapse in Acute Myeloid Leukemia

Venetoclax induces rapid elimination of NPM1 mutant measurable residual disease in combination with low‐intensity chemotherapy in acute myeloid leukaemia

A Prospective Phase 2 Study of Venetoclax and Low Dose Ara-C (VALDAC) to Target Rising Molecular Measurable Residual Disease and Early Relapse in Acute Myeloid Leukemia

Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission

Cellular distribution of IDH mutations in AML during morphologic remission

High Sensitivity Detection of FLT3-ITD Measurable Residual Disease By Deep Sequencing Prior to Hematopoietic Cell Transplant Is Highly Prognostic for Outcome in Acute Myeloid Leukemia

Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy

Germline Missense Variants in SH2B3 Underpin Platelet Count Variation and Inherited MPN

ALLG AMLM26 Phase 1B/2 Study Investigating Novel Therapies to Target Early Relapse and Clonal Evolution As Pre-Emptive Therapy in AML (INTERCEPT): A Multi-Arm, Precision-Based, Recursive, Platform Trial

Suchergebnisse filtern